Tag: hepatitis c market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Hepatitis C Market Expected To Become By 2029 Compared With Its 2025 Level?

The hepatitis c market size has seen swift expansion in recent years. It is anticipated to increase from $67.17 billion in 2024 to $75.72 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be ascribed to elements such as blood transfusion practices, injection drug use, the scarcity of treatment alternatives, and the introduction of direct-acting antivirals (DaaS).

The hepatitis c market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $132.21 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.0%. Factors contributing to this growth during the forecast period include global initiatives for elimination, enhancements in testing and screening procedures, increased expenditure on healthcare, the incorporation of telemedicine, and the development of novel therapeutic combinations. Key trends identified for the forecast period encompass the availability of accessible and affordable treatments, a sharpened focus on high-risk populations, advancements in drug formulations, increased collaborative efforts and partnerships, and the wider adoption of telehealth and digital solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Which Industry Drivers Are Expected To Accelerate The Hepatitis C Market From 2025 To 2029?

The growth of the hepatitis C market is projected to be driven by an uptick in viral infections. Viral infections are defined as ailments caused by a virus within the body. Treatment for Hepatitis C diminishes viral infection by eliminating the virus and restoring the immune system’s function in patients once the viral load is cleared. As an illustration, in August 2024, the Centers for Disease Control and Prevention, a US-based public health agency, reported that the proportion of individuals with Parvovirus B19, a seasonal respiratory viral infection, rose across all age groups, increasing from 3% between 2022–2024 to 10% by June 2024; the most substantial increase was noted in children aged 5–9 years, where prevalence escalated from 15% during 2022–2024 to 40% by June 2024. Additionally, the percentage of pooled samples containing parvovirus B19 DNA levels markedly grew from 1.5% in December 2023 to 19.9% in June 2024. Thus, the escalating incidence of viral infections is stimulating the hepatitis C market.

What Are The Emerging Segments Gaining Attention In The Hepatitis C Market?

The hepatitis cmarket covered in this report is segmented –

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types

2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments

3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies

5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6

2) By Acute Hepatitis C: Symptomatic; Asymptomatic

3) By Other Types: Mixed Infections; Superinfection

What Key Innovation Trends Are Fueling Advancements In The Hepatitis C Market?

A significant trend gaining prominence in the hepatitis C market involves advancements in diagnostic technologies for hepatitis C. Major companies operating within the hepatitis C market are embracing new technologies to uphold their market position. For example, in July 2022, F. Hoffmann-La Roche Ltd., a pharmaceutical and diagnostics company based in Switzerland, released its Elecsys HCV Duo immunoassay in regions that accept the CE Mark. This Elecsys HCV Duo immunoassay enables the independent and simultaneous determination of hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. The test is capable of identifying patients who are recovering from or displaying symptoms of a chronic infection, which might lead to other conditions such as liver cancer and various early-stage diseases.

Who Are The Major Companies Operating In The Hepatitis C Market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Region Is Projected To Lead The Hepatitis C Market During The Forecast Period?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hepatitis C Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Market 2025, By The Business Research Company

Hepatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Non Alcoholic Steatohepatitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Projected CAGR for the Hepatitis C Market Size from 2025 to 2034?#_x000D_

In recent times, the size of the hepatitis C market has experienced a significant increase. It is anticipated to expand from $67.17 billion in 2024 to $75.72 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.7%. Factors contributing to the growth during this historic period include blood transfusion practices, the use of injection drugs, limited available treatments, along with the evolution of direct-acting antivirals (DaaS)._x000D_

_x000D_

The market size for hepatitis c is predicted to expand swiftly in the coming years, with projections saying it will reach$132.21 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%. The projected growth within this period can be linked to efforts aimed at global eradication, enhancements in testing and screening procedures, increased expenditure on healthcare, the incorporation of telemedicine, and the emergence of innovative therapeutic combinations. Key trends to watch during the forecast period encompass affordable and accessible therapies, emphasis on intensively at-risk communities, advancements in drug formulations, cooperative initiatives and partnerships, and the incorporation of telehealth and digital technologies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Hepatitis C Market?#_x000D_

The hepatitis C market’s growth is predicted to be driven by a rise in viral infections. A viral infection is the result of a virus invading the human body. Hepatitis C treatments aim to diminish these infections by eliminating them and reestablishing the immune response in patients, post-clearance of the virus. For example, data from the US-based Centers for Disease Control and Prevention, in August 2024, revealed a surge in the percentage of individuals infected with Parvovirus B19 – a seasonal respiratory virus, across all age categories. It increased from 3% during 2022-2024 to 10% by June 2024, with the most noticeable spike among children aged 5-9 years, where it escalated from 15% during 2022-2024 to 40% in June 2024. Also, the percentage of combined samples with parvovirus B19 DNA levels saw a considerable rise from 1.5% in December 2023 to 19.9% by June 2024. Hence, this escalation in viral infections serves as a catalyst for the expansion of the hepatitis C market._x000D_

_x000D_

#How Is the Hepatitis C Market Segmented?#_x000D_

The hepatitis cmarket covered in this report is segmented – _x000D_

_x000D_

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types_x000D_

2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments_x000D_

3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis_x000D_

4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies_x000D_

5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings_x000D_

_x000D_

Subsegments:_x000D_

1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6 _x000D_

2) By Acute Hepatitis C: Symptomatic; Asymptomatic _x000D_

3) By Other Types: Mixed Infections; Superinfection _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Hepatitis C Market Growth?#_x000D_

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Hepatitis C Market?#_x000D_

The increasing adoption of cutting-edge diagnostic technologies for hepatitis C treatment represents a rising trend in the hepatitis C industry. Prominent corporations in this sector are employing these state-of-the-art technologies to maintain their market positioning. For instance, in July 2022, F. Hoffmann-La Roche Ltd., a pharmaceutical and diagnostics company based in Switzerland, introduced Elecsys HCV Duo immunoassay in countries that recognise the CE Mark. By using the Elecsys HCV Duo immunoassay, the hepatitis C virus (HCV) antibody status can be examined independently and concurrently from a single human serum or plasma sample. This test can pinpoint patients showing signs of chronic infection recovery, which could evolve into other more severe conditions, such as liver cancer or other early-stage diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report_x000D_

_x000D_

#How Is the Hepatitis C Market Defined and What Are Its Core Parameters?#_x000D_

Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream. _x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Hepatitis C Market from 2024 to 2025?

The market size for hepatitis C has seen significant expansion in the past few years. The growth is projected to increase from $67.17 billion in 2024 to $76.32 billion in 2025 with a compound annual growth rate (CAGR) of 13.6%. The substantial growth during the previous period can be explained by factors such as blood transfusion procedures, use of injection drugs, scarcity of treatment alternatives, and the innovation of direct-acting antivirals (DaaS).

What Is the Projected Market Size of the Hepatitis C Market?

Forecasted robust expansion is expected for the hepatitis C market in the upcoming years, as it’s anticipated to skyrocket to a valuation of $134.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The substantial growth through the forecast period is a result of international eradication strategies, enhanced testing and screening procedures, escalating healthcare expenditure, the inclusion of telemedicine, and the advent of new therapeutic mixtures. Key trends within this forecast period encompass accessible and cost-effective treatments, an emphasis on groups at high risk, advanced drug formulations, collective initiatives and alliances, and the implementation of telehealth and digital solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Who are the Major Competitors in the Hepatitis C Market Outlook?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

What Is Fueling Growth in the Hepatitis C Market?

The growth of the hepatitis C market is projected to be driven by an upsurge in viral infections. These are infections impelled by a virus in the body. The therapy for hepatitis C diminishes viral infection by eradicating it and reinstating immune response in hepatitis C patients following viral clearance. To exemplify, the Centers for Disease Control and Prevention, a health agency based in the US, denoted in August 2024 that the incidence rate of individuals with Parvovirus B19, a seasonal viral infection of the respiratory system, inflated across all age brackets, escalating from 3% in the span of 2022–2024 to 10% in June 2024. Amongst these, the most substantial increment was marked in children within the age range of 5–9 years, where the prevalence amplified from 15% in the span of 2022–2024 to 40% by June 2024. Furthermore, the number of combined samples having parvovirus B19 DNA levels has significantly ascended from 1.5% in December 2023 to 19.9% in June 2024. Therefore, the escalation in viral infections is fueling the growth of the hepatitis C market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Which Hepatitis C Market Segments Are Growing the Fastest?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Which Industry Trends Are Shaping the Future of the Hepatitis C Market?

The growing prominence of innovative diagnostic technology for hepatitis C serves as a critical trend in the hepatitis C market. Maintaining a competitive edge within the sector, established firms are leveraging new advancements. A noteworthy example is the Switzerland-based F. Hoffmann-La Roche Ltd., which in July 2022 introduced its Elecsys HCV Duo immunoassay in regions recognizing the CE Mark. Employing this immunoassay, the hepatitis C virus (HCV) antigen and antibody levels can be simultaneously and independently assessed using one plasma or serum sample from a human. This test enables the detection of patients recovering from, or showing signs of, a chronic infection that may precipitate other health conditions, such as early-stage disorders and liver cancer.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Countries Are Leading the Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

This Report Delivers Insight On:

1. How big is the hepatitis c market, and how is it changing globally?

2. Who are the major companies in the hepatitis c market, and how are they performing?

3. What are the key opportunities and risks in the hepatitis c market right now?

4. Which products or customer segments are growing the most in the hepatitis c market?

5. What factors are helping or slowing down the growth of the hepatitis c market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the hepatitis c industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Hepatitis C Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for hepatitis C has seen significant expansion in the past few years. The growth is projected to increase from $67.17 billion in 2024 to $76.32 billion in 2025 with a compound annual growth rate (CAGR) of 13.6%. The substantial growth during the previous period can be explained by factors such as blood transfusion procedures, use of injection drugs, scarcity of treatment alternatives, and the innovation of direct-acting antivirals (DaaS).

Forecasted robust expansion is expected for the hepatitis C market in the upcoming years, as it’s anticipated to skyrocket to a valuation of $134.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The substantial growth through the forecast period is a result of international eradication strategies, enhanced testing and screening procedures, escalating healthcare expenditure, the inclusion of telemedicine, and the advent of new therapeutic mixtures. Key trends within this forecast period encompass accessible and cost-effective treatments, an emphasis on groups at high risk, advanced drug formulations, collective initiatives and alliances, and the implementation of telehealth and digital solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hepatitis C Market?

The growth of the hepatitis C market is projected to be driven by an upsurge in viral infections. These are infections impelled by a virus in the body. The therapy for hepatitis C diminishes viral infection by eradicating it and reinstating immune response in hepatitis C patients following viral clearance. To exemplify, the Centers for Disease Control and Prevention, a health agency based in the US, denoted in August 2024 that the incidence rate of individuals with Parvovirus B19, a seasonal viral infection of the respiratory system, inflated across all age brackets, escalating from 3% in the span of 2022–2024 to 10% in June 2024. Amongst these, the most substantial increment was marked in children within the age range of 5–9 years, where the prevalence amplified from 15% in the span of 2022–2024 to 40% by June 2024. Furthermore, the number of combined samples having parvovirus B19 DNA levels has significantly ascended from 1.5% in December 2023 to 19.9% in June 2024. Therefore, the escalation in viral infections is fueling the growth of the hepatitis C market.

Which Key Market Segments Comprise the Hepatitis C Market and Drive Its Revenue Growth?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Which Areas Are Leading Regions in the Hepatitis C Market Expansion Across the Globe?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theHepatitis C Market Over the Coming Years?

The growing prominence of innovative diagnostic technology for hepatitis C serves as a critical trend in the hepatitis C market. Maintaining a competitive edge within the sector, established firms are leveraging new advancements. A noteworthy example is the Switzerland-based F. Hoffmann-La Roche Ltd., which in July 2022 introduced its Elecsys HCV Duo immunoassay in regions recognizing the CE Mark. Employing this immunoassay, the hepatitis C virus (HCV) antigen and antibody levels can be simultaneously and independently assessed using one plasma or serum sample from a human. This test enables the detection of patients recovering from, or showing signs of, a chronic infection that may precipitate other health conditions, such as early-stage disorders and liver cancer.

View the full report here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

How Is the Hepatitis C Market Conceptually Defined?

Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hepatitis C Market?

The hepatitis C market’s expansion is predicted to be driven by a surge in viral infections. These infections are the result of viruses entering the body. By eradicating the virus and restoring the immune response post-viral clearance, patients with hepatitis C can decrease their viral infection. For example, the percentage of individuals affected by Parvovirus B19, a seasonal respiratory viral infection, increased across all age groups from 3% throughout 2022-2024, to 10% in June 2024 according to data from the Centers for Disease Control and Prevention, a US-based public health agency. The most significant increase was seen in children aged 5-9 years, with prevalence rates jumping from 15% during 2022-2024 to 40% by June 2024. Furthermore, the proportion of pooled samples revealing parvovirus B19 DNA levels rose substantially from 1.5% in December 2023 to 19.9% in June 2024. Hence, the upswing in viral infections is fuelling the growth of the hepatitis C market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

#What is the Growth Potential of the Hepatitis C Market, and How Will It Perform by 2034?

The market size for hepatitis C has experienced speedy growth in the recent past. It is predicted to increase from a value of $67.17 billion in 2024 to an estimated $76.32 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. Factors contributing to this surge during the historical phase include blood transfusion procedures, use of injection drugs, a scarcity of treatment alternatives, and the invention of direct-acting antivirals (DaaS).

The market size for hepatitis C is anticipated to experience swift expansion in the upcoming years, increasing to $134.03 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 15.1%. The surge during this projected period can be linked to coordinated global eradication approaches, enhanced testing procedures and screenings, spiraling healthcare expenses, the incorporation of telemedicine, and the emergence of innovative therapy combinations. Principal trends predicted for this period involve accessible and cost-effective treatment options, emphasis on markedly at-risk demographics, refinement of drug formulas, symbiotic collaborations and partnerships, along with the integration of telehealth and digital advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

What Are the Key Market Innovations in theHepatitis C Market Over the Coming Years?

Emerging technologies in hepatitis C diagnostics are becoming a predominant trend in the hepatitic C market. Prominent organizations in the market are employing these new technologies to maintain their market status. Case in point, F. Hoffmann-La Roche Ltd, a pharmaceutical and diagnostics firm from Switzerland, introduced Elecsys HCV Duo immunoassay in countries that are CE Mark compliant in July 2022. The immunoassay Elecsys HCV Duo now gives the ability to independently and concurrently determine the hepatitis C virus (HCV) antigen and antibody status from a single serum or plasma sample from a human. It can diagnose patients showing signs of recovery or chronic infection symptoms that could potentially lead to other illnesses such as liver cancer and other early-stage diseases.

Who Are the Top Companies Driving Innovation and Growth in theHepatitis C Market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Key Market Segments Comprise the Hepatitis C Market and Drive Its Revenue Growth?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Which Regions Are Emerging as Leaders in the Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Hepatitis C Maret 2025, By The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the hepatitis c market right now?

The size of the hepatitis C market has experienced swift expansion in the recent past. It is projected to rise from $67.17 billion in 2024 to reach $76.32 billion by 2025, presenting a compound annual growth rate (CAGR) of 13.6%. The increase during the historic timeframe is associated with factors such as blood transfusion procedures, usage of injected drugs, insufficient treatment alternatives, and the emergence of direct-acting antivirals (DaaS).

How fast Is the hepatitis c market expected to grow, and what’s its future value?

Anticipated brisk expansion in the hepatitis C market size is evident in the forthcoming years. The market is set to surge to $134.03 billion by 2029, showcasing a compound annual growth rate (CAGR) of 15.1%. Factors propelling this growth can be pinpointed to global eradication endeavors, enhanced testing and screening protocols, increased expenditure on healthcare, telemedicine integration, and the rise of new therapeutic combinations. In the predicted period, key trends comprise accessible and affordable therapy, concentration on high-risk demographics, ameliorated drug formulations, combined efforts and cooperation, along with the inclusion of telehealth and digital-based solutions.

Get your hepatitis c market report here!

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

What are the leading drivers of growth in the hepatitis c market?

The hepatitis C market is expected to witness accelerated growth as a result of a rise in viral infections. These infections are initiated by viruses within the body. The treatment for hepatitis C reduces this infection by eliminating it and re-establishing the immune response once the virus is cleared in hepatitis C patients. For example, in August 2024, the Centers for Disease Control and Prevention, a public health agency in the US, reported a rise in the presence of Parvovirus B19, a seasonal respiratory viral infection. The infection rate in individuals across all age groups jumped from 3% in 2022–2024 to 10% in June 2024. The highest increase was observed in children aged between 5–9 years. In this age group, the prevalence leaped from 15% in 2022–2024 to 40% by June 2024. Additionally, there was a significant rise in the percentage of combined samples carrying parvovirus B19 DNA levels, from 1.5% in December 2023 to 19.9% in June 2024. Hence, the hepatitis C market’s growth is predominantly driven by the surge in viral infections.

What are the key segments defining the hepatitis c market?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Who are the key players steering the development of the hepatitis c market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

What emerging trends are influencing the growth of the hepatitis c market?

Emerging diagnostic technologies for hepatitis C are becoming a prevalent trend in the hepatitis C market. Major companies involved in this market are leveraging these technologies to maintain their market standings. For instance, in July 2022, F. Hoffmann-La Roche Ltd., a Swiss-based pharmaceutical and diagnostics firm, introduced the Elecsys HCV Duo immunoassay to countries that recognize the CE Mark. The hepatitis C virus (HCV) antigen and antibody status can now be independently and simultaneously evaluated from a single human plasma or serum sample thanks to the Elecsys HCV Duo immunoassay. This test can identify patients who are either recovering or show symptoms of chronic infection that might lead to other conditions like liver cancer and early-stage illnesses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

Which regions are most influential in expanding the hepatitis c market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Hepatitis C Market from 2025 to 2034, and What Factors Influence It?

The hepatitis C market has expanded rapidly in recent years and is projected to grow from $67.17 billion in 2024 to $76.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.6%. This growth in the historical period was driven by factors such as blood transfusion practices, injection drug use, limited treatment options, and the development of direct-acting antivirals (DAAs).

The hepatitis C market is projected to experience significant growth in the coming years, reaching $134.03 billion by 2029 with a compound annual growth rate (CAGR) of 15.1%. Growth during this period will be driven by global eradication initiatives, enhanced screening and diagnostics, increased healthcare expenditures, telemedicine integration, and the development of new therapeutic combinations. Key trends include greater accessibility and affordability of treatment, targeted efforts for high-risk populations, advancements in drug formulations, collaborative partnerships, and the rise of digital healthcare solutions.

What Key Drivers Are Accelerating the Growth of the hepatitis c Market During the Forecast Period?

A rise in viral infections is anticipated to drive the expansion of the hepatitis C market. Viral infections are illnesses caused by viruses in the body. Hepatitis C treatment helps decrease viral infections by eliminating the virus and restoring immune function in hepatitis C patients following viral clearance. For instance, in August 2024, the Centers for Disease Control and Prevention, a US-based public health organization, reported that cases of Parvovirus B19, a seasonal respiratory infection, increased across all age groups, rising from 3% between 2022 and 2024 to 10% by June 2024. The most significant increase was seen in children aged 5–9 years, where prevalence surged from 15% during 2022–2024 to 40% in June 2024. Additionally, pooled samples containing parvovirus B19 DNA levels rose sharply from 1.5% in December 2023 to 19.9% in June 2024. Consequently, the rising incidence of viral infections is fueling the growth of the hepatitis C market.

Request Your Free Hepatitis C Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Who Are the Leading Players Fueling Growth in the Hepatitis C Market?

Major companies operating in the hepatitis C market include:

• Pfizer Inc._x000D_

• Johnson & Johnson Services Inc._x000D_

• F. Hoffman La Roche Ltd._x000D_

• Merck & Co. Inc._x000D_

• AbbVie Inc._x000D_

What Are the Emerging Trends Shaping the Future of the Hepatitis C Market?

Advances in diagnostic technologies for hepatitis C are a key trend gaining traction in the hepatitis C market. Leading companies in the market are adopting new technologies to maintain their competitive edge. For example, in July 2022, F. Hoffmann-La Roche Ltd., a Swiss pharmaceutical and diagnostics company, launched the Elecsys HCV Duo immunoassay in countries accepting the CE Mark. This test allows for the independent and simultaneous determination of both hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. It can help identify patients recovering or showing symptoms of chronic infections that could lead to conditions like liver cancer.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Key Segments Define the Structure of the Hepatitis C Market and Their Growth Potential?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Which Regions Are Driving Growth in the Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Hepatitis C Market?

Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream.

Browse Through More Similar Reports By The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: